Progress of the study of pericytes and their potential research value in adenomyosis
article
OA: diamond
CC0
AI-generated summary
This review explores pericyte markers, their roles in angiogenesis and fibrosis, and their potential connections to the pathophysiology and development of adenomyosis.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
Pericytes (PCs) are versatile cells integral to the microcirculation wall, exhibiting specific stem cell traits. They are essential in modulating blood flow, ensuring vascular permeability, maintaining homeostasis, and aiding tissue repair process. Given their involvement in numerous disease-related pathological and physiological processes, the regulation of PCs has emerged as a focal point of research. Adenomyosis is characterized by the presence of active endometrial glands and stroma encased by an enlarged and proliferative myometrial layer, further accompanied by fibrosis and new blood vessel formation. This distinct pathological condition might be intricately linked with PCs. This article comprehensively reviews the markers associated with PCs, their contributions to angiogenesis, blood flow modulation, and fibrotic processes. Moreover, it provides a comprehensive overview of the current research on adenomyosis pathophysiology, emphasizing the potential correlation and future implications regarding PCs and the development of adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (100)
- Corroborating evidence for platelet-induced epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis via openalex
- Four subtypes of adenomyosis assessed by magnetic resonance imaging and their specification via openalex
- Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A via openalex
- Myofibroblasts Are Evidence of Chronic Tissue Microtrauma at the Endometrial-Myometrial Junctional Zone in Uteri With Adenomyosis via openalex
- Pathogenesis and malignant transformation of adenomyosis (Review) via openalex
- Pathophysiology of adenomyosis via openalex
- Phenotypic characterization of adenomyosis occurring at the inner and outer myometrium via openalex
- Role of angiogenesis in adenomyosis-associated abnormal uterine bleeding and subfertility: a systematic review via openalex
- The elusive adenomyosis of the uterus—revisited via openalex
- Transforming growth factor β1 signaling coincides with epithelial–mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice via openalex
- Tumor-like intravascular proliferations of the stroma in adenomyosis. via openalex
- Ultramicro-trauma in the endometrial-myometrial junctional zone and pale cell migration in adenomyosis via openalex
- Uterine cavity matrix metalloproteinases and cytokines in patients with leiomyoma, adenomyosis or endometrial polyp via openalex
- Vascular Involvement in Adenomyosis: Report of a Large Series of a Common Phenomenon With Observations on the Pathogenesis of Adenomyosis via openalex
- W2021467952 via openalex
- W2032942532 via openalex
- W2033247060 via openalex
- W2041357218 via openalex
- W2042198997 via openalex
- W2050025717 via openalex
- W2072162746 via openalex
- W2073290778 via openalex
- W2073913252 via openalex
- W2074196937 via openalex
- W2076491580 via openalex
- W2091684966 via openalex
- W2095718854 via openalex
- W2096879602 via openalex
- W2098546432 via openalex
- W2099313535 via openalex
- W2105213856 via openalex
- W2106365668 via openalex
- W2112219075 via openalex
- W2117413404 via openalex
- W2117479856 via openalex
- W2120749461 via openalex
- W2132069404 via openalex
- W2138385394 via openalex
- W2156757115 via openalex
- W2166352034 via openalex
- W2167609020 via openalex
- W2187554387 via openalex
- W2295873347 via openalex
- W2304917549 via openalex
- W2484962773 via openalex
- W2521354182 via openalex
- W2532729595 via openalex
- W2597632520 via openalex
- W2735080953 via openalex
- W2736594300 via openalex
- W2745768411 via openalex
- W2763985063 via openalex
- W2766389820 via openalex
- W2770429142 via openalex
- W2790518348 via openalex
- W2792969825 via openalex
- W2805026728 via openalex
- W2810136386 via openalex
- W2883018382 via openalex
- W2904014978 via openalex
- W2921280620 via openalex
- W2923498017 via openalex
- W2927527132 via openalex
- W3006027588 via openalex
- W3013093478 via openalex
- W3032077630 via openalex
- W3095453421 via openalex
- W3100337334 via openalex
- W3112463124 via openalex
- W3113632690 via openalex
- W3119670942 via openalex
- W3128221641 via openalex
- W3129022034 via openalex
- W3130987271 via openalex
- W3135032927 via openalex
- W3135289098 via openalex
- W3157760222 via openalex
- W3159733809 via openalex
- W3162051384 via openalex
- W3165260470 via openalex
- W3176209527 via openalex
- W3183104967 via openalex
- W3194791332 via openalex
- W3197523306 via openalex
- W3199261356 via openalex
- W3199841344 via openalex
- W3206380994 via openalex
- W3207264335 via openalex
- W3208609721 via openalex
- W3208894687 via openalex
- W3211424489 via openalex
- W4200245776 via openalex
- W4205708542 via openalex
- W4213458780 via openalex
- W4225559363 via openalex
- W4250731522 via openalex
- W4318773396 via openalex
- W128151115 via openalex
- W983570887 via openalex
- W1488565908 via openalex
Source provenance
- europepmc
- last seen: 2026-06-04T01:30:01.192114+00:00
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
- pubmed
- last seen: 2026-05-16T00:32:30.646248+00:00
License: CC0
· commercial use OK